[ad_1]
Close-up of a vaccine produced by AstraZeneca – Photo: REUTERS
“Of the 30 blood clots as of March 24, sadly seven people have died,” the agency told AFP.
Previously, on April 1, British health officials confirmed 30 cases of blood clotting after vaccination by AstraZeneca. A similar situation has not been observed in the user of the Pfizer-BioNTech vaccine.
On the same day, the German Vaccine Commission recommended that those under the age of 60 who received the first dose of COVID-19 from AstraZeneca should receive a second dose from another manufacturer, due to concerns about thrombosis side effects. Dangerous but rare veins
Canada has also asked localities to stop administering AstraZeneca’s COVID-19 vaccines to people under the age of 55, pending further analysis of the benefits and risks of the vaccine based on age and gender.
This decision was made after the country deployed 300,000 doses of the vaccine produced by AstraZeneca and did not register dangerous complications.
At the moment, some countries are restricting the use of the British pharmaceutical company’s vaccine, while others continue to use it.
Vietnam also received 811,200 doses of the COVID-19 vaccine produced by AstraZeneca through the COVAX mechanism on April 1. These vaccines will be coordinated by the Ministry of Health and distributed to the localities to organize the vaccination in April.
The AstraZeneca vaccine is the first COVID-19 vaccine approved for circulation in Vietnam. The Vietnam Vaccine Anonymous Society (VNVC) has ordered 30 million doses of the COVID-19 vaccine from this company in 2021. The first batch of 117,600 doses has returned to Vietnam on February 24.
